Inogen Announces Participation in the Piper Jaffray 30th Annual Healthcare Conference
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the Piper Jaffray 30th Annual Healthcare Conference in New York City.
Inogen’s President and CEO Scott Wilkinson and CFO Alison Bauerlein are scheduled to present on Thursday, November 29, 2018 at 8:30 a.m. ET at the Piper Jaffray 30th Annual Healthcare Conference. Interested parties can access the live audio webcast from the Events section of the Investor Relations page on the Inogen website at www.inogen.com. A webcast replay will be available approximately one hour after the conclusion of the live presentation and will remain available for 90 days.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
About Inogen
Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181115005236/en/
Inogen
Investor Relations Contact:
Matt Bacso,
CFA
805-879-8205
or
Media Contact:
Byron Myers
805-562-0503
Source: Inogen, Inc.
Released November 15, 2018